4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001415889-24-029376
Chief Operating Officer sold 40,000 shares at an average $12.35 ($493,859)
- Chief Operating Officer acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dorsey Brian Chief Operating Officer | 2024-12-11 | Option exercise 10b5-1 | +15,000 | $0.64 | $9,600 | 21,024 | D |
| Dorsey Brian Chief Operating Officer | 2024-12-11 | Sale 10b5-1 | −15,000 | $12.43 | $186,426 | 6,024 | D |
| Dorsey Brian Chief Operating Officer | 2024-12-12 | Option exercise 10b5-1 | +25,000 | $0.64 | $16,000 | 31,024 | D |
| Dorsey Brian Chief Operating Officer | 2024-12-12 | Sale 10b5-1 | −25,000 | $12.30 | $307,433 | 6,024 | D |
| Derivatives | |||||||
| Dorsey Brian Chief Operating Officer | 2024-12-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 46,828 | D | ||
| Dorsey Brian Chief Operating Officer | 2024-12-12 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 21,828 | D | ||
| Open-market sales · 40,000 sh · avg $12.35 · $493,859 | |||||||
Loading xslF345X05/form4-12142024_121223.xml…